To
All Trading Members of the Exchange
sub: Order under Sections 11, 11(4), 11A And 11B of The Securities and Exchange Board Of India Act, 1992, In re Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the matter of Venmax Drugs and Pharmaceuticals Limited (VDPL).
Attention of the trading members is invited to the Exchange Notice No. 20171218-41 dated December 18, 2017 where in SEBI vide its Order no. WTM/MPB/ISD/ 110 /2017 dated December 18, 2017 has inter-alia directed that the promoters and directors in VDPL are permitted only to buy the securities of VDPL. The shares held by the promoters and directors in VDPL shall not be allowed to be transferred for sale by the depositories.
SEBI, now vide its Order no. WTM/MPB/SEBI/ISD/ 51 /2018 dated October 29, 2018 hereby confirm the directions issued against VDPL (PAN: AAACY1073C) vide interim order dated December 18, 2017.
This Order shall come into force w.e.f. October 30, 2018
A copy of the said Order is attached herewith and also available on the SEBI website www.sebi.gov.in.
Trading members are advised to take note of the same and ensure compliance.
Ena Janvalekar Shaila Valsan
Sr. Manager Manager
Surveillance Surveillance
Date: October 30, 2018
|